| Application no. and date | 12173228.3 (espacenet) (Federated) (European Patent Register), 20080724 | | Patent/reg. no. and date | DK/EP 2503005, 20150902 | | Publication date | 20120926 | | Priority no. and date | IT MI20071616, 20070803 | | EP pub. no. and date |
EP 2503005 20120926 | | Effective date | | | Applicant/owner | Cassiopea S.p.A., Via C. Colombo, 1
20020 Lainate (MI), IT | | Applicant ref. no. | P53937DK03 | | Inventor | Ajani, Mauro, Via C. Colombo, 1
20020 Lainate (MI), IT,
Moro, Luigi, Via C. Colombo, 1
20020 Lainate (MI), IT | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/573 (2006.01) , A61P 5/28 (2006.01) , C07J 5/00 (2006.01) , C12P 33/00 (2006.01) | | Title | Cortexolon-17alfa-propionat i krystallinsk hydratform IV | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2025 00047 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
